Price of Mounjaro to be discounted in UK pharmacies

The UK government has announced that the price of Mounjaro, a diabetes medication, will be discounted in UK pharmacies. This decision comes after concerns were raised over a potential 170% price increase for the drug. The rebate, provided by the drug's manufacturer, Eli Lilly, is expected to alleviate the financial burden on patients. However, experts have cautioned that the cost of Mounjaro will still see a significant jump, despite the discount. Mounjaro, a once-weekly injectable medication, has been hailed as a breakthrough in the treatment of type 2 diabetes. The drug has shown impressive results in clinical trials, leading to its recent approval for use in the UK. The announcement of the price discount aims to ensure that Mounjaro remains accessible to those who rely on it for their diabetes management. However, the lingering concerns over the overall cost of the medication highlight the ongoing challenges in balancing patient affordability and the financial viability of innovative pharmaceutical products.